She Leads Biotech

She Leads Biotech

By Sharron CoxScienceLife Sciences
Download on the App Store

She Leads Biotech episodes

  • S4 E17, Adrienne Mendoza - Chief Operating Officer of BBG Advanced Therapies

    Solving More Than Science with Adrienne Mendoza


    Cell and gene therapy is advancing rapidly, but science alone isn’t enough.

    In this episode of She Leads Biotech, Adrienne Mendoza, Chief Operating Officer of BBG Advanced Therapies, shares what’s really needed to move the field forward, from improving access and infrastructure to rethinking how these therapies reach patients.

    We also explore her journey over the past year, building a stronger presence in the industry, translating complex science for broader audiences, and the realities of leading through a challenging and evolving market.

    A practical and honest look at where the field is today, and what it will take to get to the next stage.


    Chapters

    00:00 Introduction
    02:00 Stepping into a New Role at BBG Advanced Therapies
    05:00 How the Role of a COO Evolves
    08:30 Building Presence and Community in CGT
    12:00 Making Complex Science Understandable
    16:00 The Mobile Leukapheresis Bus
    21:00 Access Challenges in Cell & Gene Therapy
    27:00 What Needs to Change in the System
    33:00 Industry Challenges and Optimism
    38:00 What the Next 5 Years Could Look Like
    41:00 Life Outside of Biotech


    #SheLeadsBiotech #CellAndGeneTherapy #BiotechLeadership #LifeSciences #CNAUSAExecutiveSearch

    43 min
  • S4 E16, Allisa Song & Mackenzie Andrews from Mu Medical

    Rethinking Eye Care: From NanoDropper to Mu Medical

    What started as a student project has turned into a company reshaping how eye care is delivered.

    In this episode of She Leads Biotech, we’re joined by Allisa Song, CEO of Mu Medical, and Mackenzie Andrews, CCO, to talk about the journey from an idea sparked in a research lab to a product now used across thousands of clinics.

    They share how a simple question, why are eye drops too big, led to a solution that improves patient outcomes, reduces waste, and is now evolving into something much bigger.

    We also get into co-founder dynamics, building in a complex healthcare system, and the reality of being young female leaders in a traditionally male-dominated space.

    A practical, honest conversation about building, scaling, and challenging assumptions in healthcare.

    Chapters

    00:00 Introduction
    01:30 Meet Allisa & Mackenzie
    04:00 From Research Lab to Startup Idea
    08:30 The Eye Drop Problem Explained
    13:00 Building NanoDropper
    18:30 When It Became a Real Business
    22:00 Product Demo & Clinical Impact
    26:00 Go-to-Market Strategy
    30:00 Working with Insurers, Clinics & Pharma
    34:00 Evolving into Mu Medical
    38:00 Co-Founder Dynamics & Trust
    42:00 Being Women in a Male-Dominated Industry
    47:00 Advice for Founders
    51:00 What’s Next for Mu Medical

    Listen / Watch:
    Spotify | YouTube

    #SheLeadsBiotech #MedTech #HealthcareInnovation #WomenInBiotech #CNAUSAExecutiveSearch

    55 min
  • S4 E15 - Connie Chang, Chief Operating Officer of ONL Therapeutics

    Finding Your Path in Biotech with Connie Chang

    Careers in biotech rarely follow a straight line.

    In this episode of She Leads Biotech, we speak with Connie Chang, Chief Operating Officer of ONL Therapeutics, about a career that has spanned big pharma, academia, and emerging biotech, and how each step has shaped the way she leads today.

    Connie shares how early career decisions don’t always define where you end up, and why sometimes “the career picks you” rather than the other way around.

    We explore the reality of moving between very different environments, from highly structured global organizations to small, fast-moving biotech companies, and what it really takes to adapt and succeed in both.

    This conversation also highlights the importance of community throughout your career, the role academia plays in driving innovation, and the personal side of leadership, including navigating family decisions, career risks, and the pressure many women face as they progress into senior roles.

    A thoughtful and honest discussion on building a career, leading with intention, and continuing to grow, even when you’re already at the top.

    Chapters

    00:00 Introduction
    01:30 How Connie Found Biotech
    04:00 Harvard, Community, and Early Influences
    06:30 Big Pharma, Academia, and Connecting the Dots
    10:00 Taking Career Risks and Moving to Michigan
    14:30 ONL Therapeutics and the Mission Behind the Science
    18:00 What a COO Role Really Looks Like in Biotech
    20:30 Building Teams in Small Biotech
    23:00 Leadership Style and Creating Trust
    26:00 Adapting Across Cultures and Environments
    29:00 Women in Leadership and Career Progression
    32:00 Being the Only One at the Table
    35:00 Self-Doubt, Growth, and Resilience
    37:30 What’s Next for ONL and Connie

    #SheLeadsBiotech #BiotechLeadership #WomenInBiotech #LifeSciences #CNAUSAExecutiveSearch

    41 min
  • S4 E14 - Samantha (Mandy) Pulliam, CEO & Chief Medical Officer at Axena Health Inc

    Leading Women’s Health Innovation: From Clinical Practice to CEO with Mandy Pulliam

    In this episode of She Leads Biotech, I’m joined by Samantha (Mandy) Pulliam, CEO and Chief Medical Officer at Axena Health, for a conversation that highlights what it really takes to lead in women’s health.

    Mandy’s journey is a unique one. She started her career as a practicing physician before stepping into the biotech and medtech space, bringing with her a deep understanding of patient care that continues to shape how she leads today.

    What stood out to me in this conversation is how intentional she has been about bridging clinical insight with innovation. At Axena Health, she’s focused on addressing conditions that have historically been under-discussed and underserved, particularly in pelvic health.

    We talk about the realities of building and leading in women’s health, where the need is significant, but awareness, funding, and attention have often lagged behind.

    Mandy shares how she approaches leadership as both a clinician and a CEO, how she thinks about patient impact alongside commercial success, and why creating solutions in this space requires both persistence and a willingness to challenge long-standing assumptions.

    This is a conversation about leadership, purpose, and the responsibility that comes with developing products that directly impact patients’ quality of life.

    And a reminder that innovation in healthcare isn’t just about new technology, it’s about truly understanding the people you’re trying to help.

    📌 Chapters

    00:00 Introduction
    01:48 Mandy’s journey from physician to CEO
    03:52 Moving from clinical practice into industry
    05:41 Why women’s health remains underserved
    07:32 The mission behind Axena Health
    09:18 Addressing pelvic health challenges
    11:05 Bridging patient care and innovation
    13:12 Leadership as both a clinician and executive
    15:20 Navigating funding and awareness gaps
    17:08 Building solutions that truly serve patients
    19:06 Commercial strategy in women’s health
    21:14 Lessons learned stepping into the CEO role
    23:02 Advice for women entering biotech leadership
    24:40 Balancing purpose with business outcomes
    26:18 The future of women’s health innovation

    🎙️ She Leads Biotech celebrates the journeys of women shaping the future of life sciences.

    Subscribe for more conversations with biotech leaders, founders, and innovators.

    #SheLeadsBiotech #WomensHealth #BiotechLeadership #LifeSciences #MedTech #WomenInBiotech #HealthcareInnovation #CNAUSAExecutiveSearch

    34 min
  • S4 E13 - Elizabeth (Beth) White, COO and Co-Founder at Orphan Therapeutics Accelerator

    Rethinking Rare Disease: A New Model for Ultra-Rare Therapies with Beth White

    In this episode of She Leads Biotech, I’m joined by Elizabeth (Beth) White, COO and Co-Founder of Orphan Therapeutics Accelerator, for a conversation that really stayed with me.

    Beth has spent her career at the intersection of science, strategy, and commercialization, and today she’s focused on one of the biggest challenges in our industry: how do we bring therapies to patients with ultra-rare diseases when the traditional biotech model simply doesn’t support them?

    As Beth explains, the science has moved forward, especially in gene and cell therapies, but the business model hasn’t kept up. And that’s leaving too many promising therapies sitting on the shelf, never reaching the patients who need them.

    What she and her team are building with the Orphan Therapeutics Accelerator is a completely different approach. A nonprofit biotech model designed to rethink how therapies are funded, developed, and ultimately delivered to patients.

    We talk about what that actually looks like in practice, from new ways of funding and partnering, to the creation of the CGT Exchange, a marketplace designed to unlock shelved assets and give them a path forward.

    This is one of those conversations that really challenges how you think about drug development, investment, and impact.

    And a reminder that behind every “ultra-rare” disease are real patients, real families, and a very real urgency to find solutions.

    📌 Chapters

    00:00 Introduction
    01:52 Why ultra-rare diseases remain underserved
    03:44 What the Orphan Therapeutics Accelerator is
    05:00 Building a completely new development model
    06:32 How the nonprofit structure works in practice
    08:39 Creating awareness and industry engagement
    10:34 Major partnerships and recent momentum
    11:39 What the CGT Exchange is and why it matters
    13:26 Can this model work at scale?
    15:08 Beth’s journey into rare disease and gene therapy
    17:01 Bridging science and business
    19:18 Leadership across pharma, biotech, and nonprofit
    21:19 Big pharma vs biotech mindset
    23:09 Leading with limited resources
    24:21 Advice for women in biotech
    25:37 Risk-taking and career decisions
    26:17 The future of rare disease development
    28:40 The role of AI in accelerating progress

    🎙️ She Leads Biotech celebrates the journeys of women shaping the future of life sciences.

    Subscribe for more conversations with biotech leaders, founders, and innovators.

    #SheLeadsBiotech #BethWhite #RareDisease #GeneTherapy #BiotechInnovation #WomenInBiotech #LifeSciences #CNAUSAExecutiveSearch

    32 min
  • S4 E12, Samantha Dale Strasser - VP Strategy at Cellular Intelligence

    From Data to Discovery: Accelerating Drug Development with Samantha Dale Strasser

    In this episode of She Leads Biotech, I sit down with Samantha Dale Strasser, VP of Strategy at Cellular Intelligence, for a fascinating conversation at the intersection of biology, computation, and patient impact.

    Samantha’s journey spans biomedical engineering, applied mathematics, physics, and a PhD at MIT, but what truly shaped her path was something deeply personal. Her father’s diagnosis with frontotemporal dementia brought into sharp focus just how far we still have to go in treating complex diseases, and sparked a determination to accelerate how we move new technologies from the lab into the hands of patients.

    We talk about her transition from academia into entrepreneurship, co-founding PepperBio, and now her work at Cellular Intelligence, where she is helping to build a platform that is fundamentally changing how we ask and answer biological questions.

    What stood out to me in this conversation is just how much the pace of science is shifting. Questions that once took years to answer can now be explored in months, opening up entirely new possibilities for drug discovery and treatment.

    We also dive into leadership, resilience, and what it really takes to build something from scratch in uncertain times.

    📌 Chapters

    00:00 Introduction
    00:10 Samantha’s background and academic journey
    02:10 Early interest in biology and computation
    04:15 A personal turning point: her father’s diagnosis
    05:32 Founding PepperBio and early entrepreneurship
    06:35 What Cellular Intelligence is building
    09:39 The role of AI and large-scale data in biology
    10:43 How speed is transforming research timelines
    11:41 Building a tech bio company
    13:26 Leadership across different stages of her career
    15:21 Motivating and growing scientific teams
    16:44 Transitioning from operator to leader
    18:29 The leadership training gap in life sciences
    20:34 Resilience and building a company during COVID
    23:44 Advice for scientists interested in entrepreneurship
    26:19 What the future holds for Samantha and the field
    28:00 A personal mission and long-term vision


    🎙️ She Leads Biotech celebrates the journeys of women shaping the future of life sciences.


    Subscribe for more conversations with biotech leaders, founders, and innovators.


    #SheLeadsBiotech #SamanthaDaleStrasser #CellularIntelligence #BiotechInnovation #DrugDiscovery #WomenInBiotech #LifeSciences #CNAUSAExecutiveSearch

    30 min
  • S4 E11, Joanna Ghayad - Founder & CEO of Joanna Ghayad Coaching

    In this episode of She Leads Biotech, Sharron Cox speaks with Joanna Ghayad, Founder & CEO of Joanna Ghayad Coaching, about leadership, influence, and the transition many scientists struggle to make as their careers grow.

    Joanna’s career has taken her from working as an oncology pharmacist supporting cancer patients at the bedside, to roles in biotech and big pharma, and ultimately to launching her own leadership coaching practice focused on developing the next generation of leaders in life sciences.

    After more than 15 years working across healthcare, biotech, and large pharmaceutical organizations, Joanna began to notice a consistent gap. Scientists are trained extensively in technical expertise, but very rarely taught how to lead teams, influence decisions, and communicate science in a way that drives business and patient impact.

    In this conversation we explore the shift from technical expert to strategic leader, why scientists often get “boxed in,” and how professionals in life sciences can take ownership of their careers rather than waiting for someone else to define the next step.

    Joanna also shares practical advice for scientists who want to grow their influence, build visibility within their organizations, and develop the leadership skills needed to move into executive roles.

    If you're working in biotech, pharma, or the broader life sciences ecosystem and thinking about your next step, this is a conversation worth listening to.

    Connect with Joanna Ghayad
    LinkedIn: Joanna Ghayad
    YouTube: The Revolutionary Stemmist

    Joanna has also generously offered listeners a complimentary 20-minute coaching session, available through the link below: https://joannaghayadcoaching.com/conference/form

    Chapters

    00:00 Introduction
    01:34 Joanna’s journey into pharmacy and oncology
    03:33 Exploring career paths during pharmacy school
    05:08 Transitioning from healthcare into biotech and pharma
    09:08 Discovering the leadership gap in life sciences
    10:30 Creating leadership training inside big pharma
    13:38 Why scientists struggle with leadership and influence
    16:08 The myth that scientists aren’t creative
    20:40 Launching Joanna Ghayad Coaching
    23:35 Moving from operator to leader
    26:13 How coaching helps scientists advance their careers
    28:20 Advice for scientists who want to grow into leadership
    32:03 Navigating power dynamics in organizations
    35:11 Authentic leadership and building respect
    37:46 How to connect with Joanna

    41 min
  • S4 E10, Megan McGill - CEO at Brenig Therapeutics

    Megan McGill | Leadership, Credibility & Persistence in Biotech

    CEO, Brenig Therapeutics

    What does it really take to build credibility as a leader in biotech?

    In this episode of She Leads Biotech, I sit down with Megan McGill, CEO of Brenig Therapeutics, to talk about leadership, persistence, and the realities women still face when building careers in the life sciences industry.

    Megan shares her journey into biotech leadership and what it takes to step into the CEO role in a competitive and evolving sector.

    One part of our conversation that really stood out was Megan’s honesty about something many women quietly experience: sometimes you have to outperform everyone else just to be taken seriously.

    We talk about the importance of credentials, preparation, and resilience, and why continuing to push forward matters, even when the room isn’t designed with you in mind.

    This conversation is an honest look at leadership, credibility, and the persistence required to succeed in biotech.


    Chapters:

    00:00 Introduction
    01:45 Megan’s career journey into biotech
    07:30 Moving into leadership roles
    13:10 The reality of credibility and gender bias
    18:20 Why credentials matter in leadership
    24:15 Advice for women building careers in biotech
    29:40 Leadership lessons as CEO of Brenig Therapeutics
    34:30 Final advice for the next generation


    🎙️ She Leads Biotech celebrates the journeys of women shaping the future of life sciences.


    Subscribe for more conversations with biotech leaders, founders, and innovators.

    #SheLeadsBiotech #MeganMcGill #BrenigTherapeutics #BiotechLeadership #WomenInBiotech #WomenInScience #LifeSciences

    47 min
  • S4 E9, Sailaja Battula - Chief Scientific Officer at Ankyra Therapeutics

    What does it really take to move from academia to industry… and then into the C-suite?

    In this episode of She Leads Biotech, I sit down with Sailaja Battula, Chief Scientific Officer at Ankyra Therapeutics, whose journey is anything but conventional.

    Born and raised on a farm in South India, Sailaja became the first in her family to attend college. She completed her PhD while raising two young children, applied for over 200 industry roles to make her transition, built immunology teams from scratch, and ultimately stepped into the CSO role at a pivotal moment for her company.

    This is a conversation about intention, discipline, leadership growth, and knowing when you are ready, even before you fully believe it yourself.

    We cover:
    • Transitioning from academia to industry
    • What hiring managers really look for
    • Building and leading discovery teams
    • Moving from VP to CSO
    • Leadership vs management in scientific roles
    • Raising a family while building a biotech career

    If you are thinking about your next move, especially into leadership, this episode is packed with clarity and practical insight.


    Chapters:

    00:00 Introduction
    01:40 Growing up on a farm in South India
    07:01 Education, marriage, and moving to the US
    08:48 Breaking into biotech with a newborn
    11:19 PhD, postdoc, and moving into immuno-oncology
    14:37 Why transitioning from academia to industry is hard
    19:21 The three questions to ask before applying for a role
    22:46 Career progression from scientist to VP
    30:12 Stepping into the CSO role at Ankyra
    36:16 What changes when you join the C-suite
    38:10 Leadership vs management in science
    40:38 Advice to her younger self
    42:03 Using LinkedIn strategically for career growth
    43:42 What’s next as CSO


    🎙️ Subscribe for more conversations with women shaping the future of biotech.


    #SheLeadsBiotech #SailajaBattula #AnkyraTherapeutics #ChiefScientificOfficer #BiotechLeadership #WomenInScience #CNAUSAExecutiveSearch

    46 min
  • s4 Ep 8 Mori Mohseni Head of Biology at Vida Vinci

    In this episode of She Leads Biotech, I sit down with Mori Mohseni, Head of Biology at VidaVinci, for a powerful conversation about persistence, purpose, and what it really takes to lead in drug discovery.

    From her early fascination with biology to pivotal roles at AstraZeneca, Novartis, BMS, and now startup biotech, Mori’s career has been defined by one recurring theme: give her the hard problem.

    We talk about what it means to search for truth in science, even when the answer isn’t what you hoped for. We explore the transition from big pharma to biotech to startup life, and why those moves were intentional. And we dive into leadership, team building, and the obsession required to move breakthrough science forward.

    This is a conversation about loving the work enough to stay with it when it’s difficult, and inspiring others to do the same.

    📌 Chapters / Timestamps

    00:00 – Introduction and Mori’s early path into science

    03:40 – Falling in love with biology and choosing research over medicine

    08:10 – The leap from academia into industry

    12:00 – A pivotal lesson: “Look for the truth” in drug discovery

    15:20 – Seeing a drug go from bench to patient

    18:45 – Big pharma vs biotech vs startup: what really changes

    23:15 – Building infrastructure from scratch in smaller companies

    27:30 – Leading as a servant leader and building strong teams

    31:40 – Advice for young scientists navigating today’s market

    35:50 – The future of biotech and the need for early innovation funding

    40:10 – Leadership in biotech means loving what you do



    38 min

About She Leads Biotech

From the publisher's feed

This is She Leads Biotech, a podcast where we have real conversations with women leading the charge in innovation, research, and entrepreneurship in the bioscience space. Each episode offers a candid…